End-of-Life Choices (Voluntary Assisted Dying) Act 2021
67Commission may issue or refuse to issue VAD substance authorisation
Start here
Get a plain-English read of 67
Turn the raw legal text into a practical explanation grounded in End-of-Life Choices (Voluntary Assisted Dying) Act 2021.
67 Commission may issue or refuse to issue VAD substance authorisation
(1) If the Commission receives a request under section 66(1) from a person’s PMP, the Commission must, as soon as reasonably practicable –
(a) issue to the PMP a VAD substance authorisation in relation to the person; or
(b) if section 68(1) applies, refuse to issue to the PMP a VAD substance authorisation in relation to the person.
(2) A VAD substance authorisation in relation to a person is an instrument in writing, in the approved form, that is signed by the Commission and that –
(a) contains the relevant details in relation to a VAD substance authorisation in respect of the person; and
(b) specifies that the person’s PMP is authorised to issue a VAD substance prescription in relation to the person.
(3) For the purposes of subsection (2)(a) , the relevant details in relation to a VAD substance authorisation in respect of a person are –
(a) the name of the person and the address at which the person is ordinarily resident; and
(b) the name of the person’s PMP at the time when the VAD substance authorisation is issued; and
(c) the details of the VAD substance to which the VAD substance prescription is to relate; and
(d) the maximum amount of the VAD substance, the supply and possession of which is to be authorised by the VAD substance prescription; and
(e) the period for which the person’s PMP is authorised to issue the VAD substance prescription.
(4) A VAD substance authorisation may relate to either of the following:
(a) a VAD substance that may be self-administered by the person to whom the VAD substance relates;
(b) a VAD substance that may be administered to the person by the AHP in relation to the person.